XML 43 R30.htm IDEA: XBRL DOCUMENT v3.25.1

Stockholders’ Equity (Tables)

12 Months Ended

Dec. 31, 2024

Equity [Abstract]

Schedule of Non-vested Shares Related Parties

The following is a summary of the Company’s non-vested shares at December 31, 2024 and 2023.

 Schedule of Non-vested Shares Related Parties

						Weighted Average
Non-Vested Shares		Number of Shares				Grant Date Fair Value
Balance - December 31, 2022			-			$	-
Granted			695,000				5.24
Vested			-				-
Cancelled/Forfeited			-				-
Balance - December 31, 2023			695,000			$	5.24
Granted			644,640			$	7.60
Vested			(1,000,000	)			6.55
Cancelled/Forfeited			-				-
Balance - December 31, 2024			339,640			$	5.30
Unrecognized Compensation		$	973,253
Weighted average period (years)			3.72

Schedule of Stock Granted

The following is a detail of the common stock granted, which is subject to the vesting provisions noted above at December 31, 2024 and December 31, 2023, respectively.

 Schedule of Stock Granted

														Director of
		CEO				CFO				Directors				Human Resources/Legal				Total
Balance - December 31, 2022			-				-				-				-				-
Granted			-				600,000				95,000				-				695,000
Vested			-				-				-				-				-
Cancelled/Forfeited			-				-				-				-				-
Balance - December 31, 2023			-				600,000				95,000				-				695,000
Granted			500,000				-				44,640				100,000				644,640
Vested			(500,000	)			(400,000	)			-				(100,000	)			(1,000,000	)
Cancelled/Forfeited			-				-				-				-				-
Balance - December 31, 2024			-				200,000				139,640				-				339,640
Unrecognized Compensation		$	-			$	479,077			$	494,176			$	-			$	973,253
Weighted average period (years)			-				1.00				2.72				-				3.72

Schedule of Stock Option Transactions

Stock option transactions for the years ended December 31, 2024 and 2023 are summarized as follows:

 Schedule of Stock Option Transactions

										Weighted								Weighted
										Average								Average
						Weighted				Remaining				Aggregate				Grant
		Number of				Average				Contractual				Intrinsic				Date
Stock Options		Options				Exercise Price				Term (Years)				Value				Fair Value
Outstanding - December 31, 2022			17,004			$	16.00				4.16			$	-
Vested and Exercisable - December 31, 2022			6,801			$	16.00				4.16			$	-
Unvested and non-exercisable - December 31, 2022			10,203			$	16.00				4.16			$	-
Granted			104,272			$	6.45											$	5.53
Exercised			-			$	-
Cancelled/Forfeited			-			$	-
Outstanding - December 31, 2023			121,276			$	7.79				6.47			$	-
Vested and Exercisable - December 31, 2023			116,174			$	7.43				6.61			$	-
Unvested and non-exercisable - December 31, 2023			5,101			$	16.00				3.16			$	-
Granted			1,054,603			$	1.78
Exercised			-			$	-
Cancelled/Forfeited			(9,798	)		$	6.45
Outstanding - December 31, 2024			2,220,684			$	2.09				6.92			$	-
Vested and Exercisable - December 31, 2024			2,220,684			$	2.09				6.92			$	-
Unvested and non-exercisable - December 31, 2024			-			$	-				-			$	-

Schedule of Fair Value of Stock Options

The fair value of these stock options was determined using a Black-Scholes option pricing model with the following inputs:

 Schedule of Fair Value of Stock Options

Expected term			7 years
Expected volatility			104	%
Expected dividends			0	%
Risk free interest rate			4.48	%

Schedule of Stock Based Compensation Expense

Stock-based compensation expense for the years ended December 31, 2024 and 2023 was as follows:

 Schedule of Stock Based Compensation Expense

Year Ended December 31,
2024				2023
$	1,609,193			$	613,801

Schedule of Fair Value of Stock Options

The fair value of these stock options was determined using a Black-Scholes option pricing model with the following inputs:

 Schedule of Fair Value of Stock Options

Expected term			7 years
Expected volatility			106	%
Expected dividends			0	%
Risk free interest rate			3.88	%

Schedule of Warrants Activity

Warrant activity for the years ended December 31, 2024 and 2023 are summarized as follows:

 Schedule of Warrants Activity

										Weighted
										Average
						Weighted				Remaining				Aggregate
		Number of				Average				Contractual				Intrinsic
Warrants		Warrants				Exercise Price				Term (Years)				Value
Outstanding - December 31, 2022			5,681,392			$	5.05				1.85			$	10,026,387
Vested and Exercisable - December 31, 2022			5,681,392			$	5.05				1.85			$	10,026,387
Unvested - December 31, 2022			-			$	-				0.00			$	-
Granted			-			$	-
Exercised			(43,814	)		$	4.73
Cancelled/Forfeited			(63,325	)		$	26.39
Outstanding - December 31, 2023			5,574,253			$	4.81				0.86			$	9,348,348
Vested and Exercisable - December 31, 2023			5,574,253			$	4.81				0.86			$	9,348,348
Unvested - December 31, 2023			-			$	-				-			$	-
Granted			-			$	-
Exercised			(1,953,308	)		$	4.73
Cancelled/Forfeited			(3,524,945	)		$	4.86
Outstanding - December 31, 2024			96,000			$	4.73				0.37			$	-
Vested and Exercisable - December 31, 2024			96,000			$	4.73				0.37			$	-
Unvested and non-exercisable - December 31, 2024			-			$	-				-			$	-

X

- Definition

Schedule Of Share Based Payment Award Stock Options Valuation Assumption [Table Text Block]

+ References

No definition available.

+ Details

Name:	SURG_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionTableTextBlock
Namespace Prefix:	SURG_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule Of Stock Based Compensation Expense [Table Text Block]

+ References

No definition available.

+ Details

Name:	SURG_ScheduleOfStockBasedCompensationExpenseTableTextBlock
Namespace Prefix:	SURG_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule Of Stock Granted [Table Text Block]

+ References

No definition available.

+ Details

Name:	SURG_ScheduleOfStockGrantedTableTextBlock
Namespace Prefix:	SURG_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration